[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_7128 

# __Off-label use of favipiravir for sars-cov-2 treatment__

## Articles mentionning the risk

* [Cirrincione_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_441.md)

## Mitigations of this risk

* [Clinical trials and research to establish safety and efficacy](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_9009.md)

## Name of the risk

Undefined safety and efficacy for SARS-CoV-2

## People affected by this risk

* [And patients](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_121.md)
* [Healthcare providers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)
* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2679.md)

## Stakeholders who can mitigate this risk

* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_401.md)
* [Regulatory agencies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)

## Technologies linked to the risk

* [Clinical trial research and data analysis tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8681.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Misinterpretation of data and results](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_3.md)

